Webcast on Demand
On demand webcast: View the webcast from the Boehringer Ingelheim press conference at the ESC 2009 in Barcelona on 30 August.
Value through Innovation16 January 2013
Stroke Prevention in Atrial Fibrillation (SPAF) News and Information
This section includes information and resources about Stroke Prevention in Atrial Fibrillation (SPAF) for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
Stroke Prevention in Atrial Fibrillation (SPAF) Press Releases
| 11.12.2012 |
Boehringer Ingelheim discontinues Phase II trial in patients with artificial heart valves |
|---|---|
| 10.12.2012 |
Treatment with Pradaxa® associated with better patient outcomes after a major bleeding event compared to warfarin |
| 05.12.2012 |
New Pradaxa® safety and efficacy data to be featured at ‘Best of ASH’ session |
| 08.11.2012 |
RELY-ABLE®: Unprecedented long-term data support safety profile and sustained efficacy of Pradaxa® for stroke prevention in AF |
| 05.11.2012 |
Pradaxa® - Development of antidote may expand range of methods to reverse anticoagulant effect during emergency situations - For Non-US, Non-UK & Non-Canadian Media Only |
SPAF Related News Room
SPAF Related Documents
Videos
-
-
Prof. Gregory Lip
- Watch the video(QT)
-
-
-
-
-
-
-
-
-
-
-
